Skip to content

Evaluation of PC+ 2.0 in Blue Care according to Triple Aim

A prospective cohort study on the effectiveness and cost-effectiveness of Primary Care Plus (PC+)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29253
Enrollment
3660
Registered
2017-10-05
Start date
2015-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measuring the effects of PC+ on referral rates to hospital care (‘substitution task’) and measuring the effects of PC+ on triple aim outcomes (patient health status, experience of care and health care costs).

Interventions

Primary Care Plus (PC+): This intervention focuses on care substitution in which medical specialists perform consultations within a primary care setting. PC+ is assumed to slow down therising health

Sponsors

Maastricht Universitair Medisch Centrum (MUMC+)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Included in the study are all adult patients (≥18 years) registered with a GP in the region Maastricht-Heuvelland who are referred during the intervention period via the TIPP system or via the GPs service desk with non-acute, non- complex health problems to the medical specialities which provide primary care plus consultations (internal medicine, neurology, orthopaedics, dermatology, ophthalmology, rheumatology, gynecology, urology, ENT and in time possibly other medical specialties) and patients who give informed consent.

Exclusion criteria

Exclusion criteria: Excluded from participation in this study are patients present in general practice with: 1) acute health problems which require immediate referral to hospital care; 2) complex health problems that require more sophisticated diagnostics or treatments not available in a PC+ setting; 3) complaints related to a prior diagnosis of diabetes mellitus, chronic obstructive pulmonary disease and/or vascular risks, i.e. conditions for which bundled payment contracts exist between regional health insurers and ZIO.

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is the referral rate from PC+ to hospital care.

Secondary

MeasureTime frame
Population health: Health status and health-related quality of life (HRQoL) will be measured with two generic, validated questionnaires: the EuroQol-5D (EQ-5D) and the 12-Item Short Form Health Survey (SF-12). Experience of care: Safety: Safety of care is measured using medical data made available by MUMC+ of patients from both study conditions concerning (1) hospital admissions and (2) emergency care visits. Medical data made available by insurance company VGZ is used to measure (3) mortality rates. - Equity: Equity of care is examined by performing subgroup analysis on SES and age. - Timeliness: Timeliness of care is examined by measuring the waiting time (in days) between the day that the patient makes an appointment through TIPP and the day of the 1st consultation with the medical specialist. - Patient centered: Patient centered care is measured using items from the CQ Index Outpatient care and items derived from the CQ Index GP care. - Efficiency: Efficiency of care is measured using TIPP data and medical data made available by the MUMC+ of patients from both experimental conditions concerning 1) average number of consultations within 6 months 2) average number of hospital admissions. In addition, for the PC+ condition the number and percentage of patients that is yet referred to hospital care after PC+ is measured. - Effectiveness: Effectiveness of care is measured with the PAM-13 questionnaire measuring the level of patient engagement in their health care.

Contacts

Public ContactVeronique Frijns
v.frijns@zio.nl043 350 6910

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)